Search

Search Constraints

You searched for: Author/Creator Delgado, Ruby

Search Results

1. Melphalan‐based autologous transplant in octogenarian multiple myeloma patients. Issue 1 (31st October 2018)

2. Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant. Issue 10 (3rd September 2016)

3. High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes. Issue 2 (28th January 2019)

4. Impact of autologous stem cell transplantation on long term renal function and associated progression-free and overall survival in multiple myeloma. Issue 13 (9th November 2020)

5. Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial. Issue 5 (May 2019)

6. High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan. Issue 6 (June 2017)

7. Impact of autologous stem cell transplantation on long term renal function and associated progression-free and overall survival in multiple myeloma. Issue 13 (9th November 2020)

8. Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma. Issue 8 (3rd August 2018)

9. Long‐term durable efficacy of autologous stem cell transplantation in POEMS syndrome. Issue 3 (21st December 2018)

10. Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis. Issue 12 (4th October 2021)